Trial
NCT02842021
Efficacy and Safety of Product S2G6T-1in Patients With Symptomatic Inflammatory Interdigital Tinea Pedis
Phase IITERMINATEDEFFICACY/FUTILITYConfidence: MEDIUM
Sponsor
Sol-Gel Technologies, Ltd.
Collaborators
—
Condition
Tinea Pedis
Intervention
S2G6T-1
Why stopped
Failed to meet success criteria
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2020-11-18